Stock movers: Hess, Chevron, Roivant Sciences, Harpoon Therapeutics

United States News News

Stock movers: Hess, Chevron, Roivant Sciences, Harpoon Therapeutics
United States Latest News,United States Headlines
  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 32 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 16%
  • Publisher: 97%

Hess Corp. Harpoon Therapeutics, Chevron, Pfizer, Roivant Sciences and Great Ajax were on the move.

Hess Corp. stock HES, -1.84% rose 3% to $167.48 after Chevron said it would buy the company for $53 billion, or $171 per share, in stock. Chevron stock CVX, -1.34% fell by 2%.

Harpoon Therapeutics stock HARP, +18.42% rose 38% as the biotech said its lung cancer drug showed “promising” antitumor activity and tolerability profile in a Phase 1/2 clinical trial. Roivant Sciences shares ROIV, -1.13% rose 14% as Roche said it would buy Telavant Holdings that Roivant owns with Pfizer for as much as $7.25 billion. Roivant is the 75% owner of the company that was only formed last year. Pfizer shares rose 0.5%, while Roche was steady in Swiss trade.Great Ajax AJX, +0.31%, a real-estate investment trust, saw its stock drop by 18% after the proposed buyout by Ellington Financial fell through.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

MarketWatch /  🏆 3. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Chevron, Hess, Roivant, Textainer, Microsoft, Alphabet, and More Stock Market MoversChevron, Hess, Roivant, Textainer, Microsoft, Alphabet, and More Stock Market MoversChevron will buy Hess in all-stock deal valued at $53 billion, Roche agrees to buy a developer of a drug for people suffering from inflammatory bowel disease...
Read more »

Roche to Buy Telavant From Roivant Sciences and Pfizer in $7.25 Bln DealRoche to Buy Telavant From Roivant Sciences and Pfizer in $7.25 Bln DealBy Adria Calatayud Roche Holding has agreed to buy Telavant Holdings from Roivant Sciences and Pfizer in a deal worth up to $7.25 billion that will give it...
Read more »

Roche to Buy Telavant from Roivant Sciences, Pfizer for $7.1 BillionRoche to Buy Telavant from Roivant Sciences, Pfizer for $7.1 BillionIt will buy immunology company Telavant Holdings from Roivant Sciences and Pfizer.
Read more »

Chevron to Buy Hess for $53 BillionChevron to Buy Hess for $53 BillionThe company said it would buy Hess in an all-stock deal worth $53 billion, in the latest sign of consolidation in an oil-and-gas industry flush with cash.
Read more »

Chevron to buy Hess Corp for $53 billion in stockChevron to buy Hess Corp for $53 billion in stockChevron to buy Hess Corp for $53 billion in stock
Read more »

Chevron to buy Hess Corp for $53 billion in all-stock dealChevron to buy Hess Corp for $53 billion in all-stock dealChevron said on Monday it will buy smaller rival Hess in a $53-billion all-stock deal. Chevron is offering $171 for every Hess share, implying a premium of…
Read more »



Render Time: 2025-02-21 10:17:29